Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement

• Egile Nagusiak: Erin D. Michos (Egilea), Tina K. Reddy (Egilea), Martha Gulati (Egilea), LaPrincess C. Brewer (Egilea), Rachel M. Bond (Egilea), Gladys P. Velarde (Egilea), Alison L. Bailey (Egilea), Melvin R. Echols (Egilea), Samar A. Nasser (Egilea), Harold E. Bays (Egilea), Ann Marie Navar (Egilea), Keith C. Ferdinand (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2021-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Cardiovascular disease (CVD) remains the leading cause of death for both women and men worldwide. In the United States (U.S.), there are significant disparities in cardiovascular risk factors and CVD outcomes among racial and ethnic minority populations, some of whom have the highest U.S. CVD incide...